Print Page

Medicine recalls

 
Canada: Recall: Duavive Tablet
 
Health Canada announces that Pfizer Canada Inc. is recalling 4 lots of Duavive Tablet (bazedoxifene 20 mg and conjugated estrogens 0.45 mg) (lot number: AH6679, X51932, DC8998, AN0290) from wholesalers and retailers because the affected lots may not meet the specification for dissolution of bazedoxifene during the product shelf-life.

Please refer to the following website in Health Canada for details: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../73183r-eng.php

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Tuesday, May 26, 2020
Issued at HKT 15:00
 
Related Information:
The United Kingdom: Company led drug alert - Duavive (conjugated oestrogen/bazed... Posted 2020-05-28
 
back